MMSI MERIT MEDICAL SYSTEMS INC

Q3 2025 10-Q

Filed: Oct 30, 2025Period ending Sep 30, 2025

Health Care

Surgical & Medical Instruments & ApparatusSEC EDGAR

MERIT MEDICAL SYSTEMS INC (MMSI) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 30, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue and YoY change not disclosed in provided text
• Profitability or margin figures not provided

+3 more insights

Risk Factors

• New leadership transition risk triggered by CEO Fred Lampropoulos resignation and Martha Aronson appointment effective October 3, 2025
• Most material update: increased labor cost risk in Mexico due to inflationary pressures and labor shortages impacting talent retention

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$384M

Net Income

$28M

Gross Margin

48.5%

Operating Margin

11.1%

Net Margin

7.2%

ROE

1.8%

Total Assets

$2.6B

Source: XBRL data from MERIT MEDICAL SYSTEMS INC Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on MERIT MEDICAL SYSTEMS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.